Intranodal immunization with antigen-encoding naked mRNA has proven to be an efficacious and safe approach to induce antitumor immunity. Thanks to its unique characteristics, mRNA can act not only as a source for antigen but also as an adjuvant for activation of the immune system. The search for additional adjuvants that can be combined with mRNA to further improve the potency of the immunization revealed Fms-like tyrosine kinase 3 (FLT3) ligand as a potent candidate. Systemic administration of the dendritic cell-activating FLT3 ligand prior to or along with mRNA immunization-enhanced priming and expansion of antigen-specific CD8+ Tcells in lymphoid organs, T-cell homing into melanoma tumors, and therapeutic activity of the intranodally administered mRNA. Both compounds demonstrate a successful combination in terms of boosting the immune response. This chapter describes methods for intranodal immunization with naked mRNA by co-administration of FLT3 ligand, which leads to strong synergistic effects.
CITATION STYLE
Kreiter, S., Diken, M., Selmi, A., Petschenka, J., Türeci, Ö., & Sahin, U. (2016). FLT3 ligand as a molecular adjuvant for naked RNA vaccines. In Methods in Molecular Biology (Vol. 1428, pp. 163–175). Humana Press Inc. https://doi.org/10.1007/978-1-4939-3625-0_11
Mendeley helps you to discover research relevant for your work.